医用可降解锌合金的生物相容性评价研究进展
王鲁宁, 尹玉霞, 石章智, 韩倩倩

Research Progress on Biocompatibility Evaluation of Biomedical Degradable Zinc Alloys
WANG Luning, YIN Yuxia, SHI Zhangzhi, HAN Qianqian
表3 锌合金植入器械必要的生物学试验项目
Table 3 Necessary biological test items for Zn alloy implantable devices
Test itemCurrent standardPurpose and methodJudgement criterion

Cellular response

Cell

toxicity

GB/

T16886.5—2017

The device/extract was cultured with cells, its potential cytotoxicity was evaluated by morphology and metabolic activity, such as MTT methodCell viability > 70% was considered non-cytotoxic. For Zn-based materials, it is generally necessary to dilute the extract over a range of concentrations. Evaluate the result in vitro and in vivo comprehensively

Tissue response

Intradermal reaction

GB/T16886.10—2017Intradermal injection of devices/materials extracts on the back skin of rabbits, to evaluate the non-specific percutaneous acute irritant effects of leachablesErythema, edema, eschar, etc., were observed and scored according to the standard. The difference between the average scores of the test sample and the control should not be greater than 1.0

Implantation & degradation

GB/

T16886.6—2015

Final devices/materials are implanted by surgical or interventional operation, and the target tissues are collected and observed at different time points to evaluate the local toxic effect of the sample on the living tissue and the degradation process (product)Different degrees of tissue reactions (aseptic inflammation, fibrous cysts around the implant, etc.) will appear after implantion. With the influence of degradation, the reaction is higher and longer relatively. It's best to set a similar marketed product control

Immune response

Delayed type hypersensitivity

GB/T16886.10—2017

The immunity is usually induced by injecting the extract of the device/material plus protein to guinea pigs, and stimulated again after 2 weeks. Then the skin reaction is observed to evaluate the potential contact sensitization of the sampleNo local skin erythema, edema and other inflammatory manifestations was considered to be no delayed type hypersensitivity reaction. Allergic reactions do not limit its use necessarily

Systemic response

Acute systemic toxicity

GB/T16886.11—2011

Mouse is used routinely. Intravenous and intraperitoneal injection of the device/material extract is contacted with animals. The systemic response is observed to evaluate whether the sample releases toxic substances and produces acute systemic toxicity. The maximum exposure dose is 50 mL·kg-1 body weight

Clinical performance (coat, skin, mucous membranes, respiration, muscles, behavior, etc.) should be observed and no indications. Gross pathological evaluation should be considered if clinically indicated

(Sub)chronic systemic toxicity

Rat is used routinely. The devices/materials or extracts are (repeatedly) contacted with animals by appropriate routes such as implantation, intravenous or intraperitoneal injection. The dose range is determined according to human safety limits. Clinical manifestations, body weight changes, hematological and clinical biochemical indicators, clinical pathological, gross pathological and histopathological analysis, etc., to evaluate whether the long-term exposure of sample to the human body will release toxic substances and produce (sub)chronic systemic toxicity

Compared with the control group, no significant difference should be observed in each index

Blood system

Hemolysis

GB/

T16886.4—2003

Direct contact of blood with the device/material or its extract, measuring the amount of hemoglobin released by erythrocytes to evaluate the degree of erythrocytelysis and hemoglobin release caused by the device/material

Hemolysis rate should be < 5%

Genetic system

Genotoxicity

GB/

T16886.3—2019

Mammalian or non-mammalian cells, bacteria, yeast or fungi are used to determine whether a device/material or extract causes genetic mutations, changes in chromosome structure and number, or other changes in DNA or genes. Bacterial gene mutation, chromosomal aberration and mouse lymphoma test are the most used in vitro tests

There should be no significant difference compared to the negative control. If the in vitro test cannot be carried out or the results are confusing, further in vivo chromosome analysis and micronucleus test of mammalian bone marrow cells should be used